Cormorant Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $18.1M | Sell |
|
|||||
|
2022
Q3 | $40.2M | Buy |
|
|||||
|
2022
Q2 | $20.1M | Buy |
|
|||||
|
2022
Q1 | $4.11M | Sell |
|
|||||
|
2021
Q4 | $11M | Sell |
|
|||||
|
2021
Q3 | $21.2M | Sell |
|
|||||
|
2021
Q2 | $28.3M | Sell |
|
|||||
|
2021
Q1 | $47.1M | Sell |
|
|||||
|
2020
Q4 | $71.4M | Buy |
|
|||||
|
2020
Q3 | $45.7M | Sell |
|
|||||
|
2020
Q2 | $57.1M | Sell |
|
|||||
|
2020
Q1 | $65.3M | Sell |
|
|||||
|
2019
Q4 | $165M | Sell |
|
|||||
|
2019
Q3 | $125M | Buy |
|
|||||
|
2019
Q2 | $113M | Buy |
|
|||||
|
2019
Q1 | $78.8M | Sell |
|
|||||
|
2018
Q4 | $74.3M | Sell |
|
|||||
|
2018
Q3 | $85.3M | Sell |
|
|||||
|
2018
Q2 | $94.6M | Hold |
|
|||||
|
2018
Q1 | $58.9M | Buy |
|
|||||
|
2017
Q4 | $22.5M | Buy |
|
|||||
|
2017
Q3 | $11.7M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $10.6M | Hold |
|
|||||
|
2015
Q4 | $15.7M | Buy |
|
|||||
|
2015
Q3 | $8.78M | Buy |
|